Long-term follow-up of mdd patients who respond to deep rtms: A brief report

Oded Rosenberg, Limor Dinur Klein, Roman Gersner, Moshe Kotler, Abraham Zangen, Pinhas Dannon

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Background: Deep transcranial magnetic stimulation (dTMS) is effective in treatment of Major Depressive Disorder (MDD), and in re-treatment in case of relapse. Our study evaluates the long-term durability of dTMS in MDD. Method: Seventeen patients that responded to dTMS treatment evaluated. Follow-up period was 9.3 months. Patients were considered as relapsed if: HDRS (Hamilton Depression Rating Scale) score was 16 points or more, in case of change in antidepressants, hospitalization due to exacerbation, referral to ECT. Results: Six months after last treatment three patients relapsed (17.6%). During the follow-up of 9.3 months, nine relapsed. Relapse rate was 5.6 per 100 person-months. Patients continued to improve in HDRS following the treatment. We have found number of treatment sessions, stimulation, age, age of depressive disorder onset, length of depressive episode prior to the first treatment, as well as number of depressive episodes to have no predictive value regarding propensity to relapse in these patients. Limitations: The study’s main limitations are the relatively small sample size, patients differing in follow-up periods and the lack of a control group. Conclusion: Relapse rates after dTMS are comparable to pharmacotherapy and ECT.

Original languageEnglish
Pages (from-to)17-24
Number of pages8
JournalIsrael Journal of Psychiatry
Issue number1
StatePublished - 1 Jul 2015

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health


Dive into the research topics of 'Long-term follow-up of mdd patients who respond to deep rtms: A brief report'. Together they form a unique fingerprint.

Cite this